Modulation of cis-Diamminedichloroplatinum (II) Accumulation and Cytotoxicity by Spermine in Sensitive and Resistant Human Ovarian Carcinoma Cells

By Marverti G.   Andrews P.A.   Piccinini G.   Ghiaroni S.   Barbieri D.   Moruzzi M.S.  

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 669-675

Elsevier

Access to resources Recommend Favorite

A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells

By Kanamori Y.   Kigawa J.   Minagawa Y.   Irie T.   Oishi T.   Shimada M.   Takahashi M.   Nakamura T.   Sato K.   Terakawa N.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1802-1806

Elsevier

Access to resources Recommend Favorite

Lisofylline Sensitizes p53 Mutant Human Ovarian Carcinoma Cells to the Cytotoxic Effects ofcis-Diamminedichloroplatinum(II)

By Husain A.   Rosales N.   Schwartz G.K.   Spriggs D.R.  

Gynecologic Oncology, Vol. 70, Iss. 1, 1998-07 ,pp. : 17-22

Elsevier

Access to resources Recommend Favorite

Resistance Mechanisms Determining the In Vitro Sensitivity to Paclitaxel of Tumour Cells Cultured from Patients with Ovarian Cancer

By Baguley B.C.   Marshall E.S.   Whittaker J.R.   Dotchin M.C.   Nixon J.   McCrystal M.R.   Finlay G.J.   Matthews J.H.L.   Holdaway K.M.   van Zijl P.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 230-237

Elsevier

Access to resources Recommend Favorite

Long-term results of chemoradiotherapy for locally advanced esophageal cancer, using daily low-dose 5-fluorouracil and cis-diammine-dichloro-platinum (CDDP)

By Sasamoto Ryuta   Sakai Kunio   Inakoshi Hideki   Sueyama Hiroo   Saito Mari   Sugita Tadashi   Tsuchida Emiko   Ito Takeshi   Matsumoto Yasuo   Yamanoi Tadayoshi   Abe Eisuke   Yamana Nobuko   Sasai Keisuke  

International Journal of Clinical Oncology, Vol. 12, Iss. 1, 2007-02 ,pp. : 25-30

Springer Publishing Company

Access to resources Recommend Favorite